LA Times Owner Faces Investor Suit Over Drug Co.'s Woes
By Emilie Ruscoe · October 30, 2024, 9:14 PM EDT
Officers and directors of biotechnology company ImmunityBio Inc., including L.A. Times owner Patrick Soon-Shiong, face a shareholder's derivative complaint alleging the company concealed issues affecting a path to regulatory approval for...
To view the full article, register now.